Evidence map›Paper›PMID 41089659›Full record

ArticleFrontiers in neuroscience2025

GenCPM: a toolbox for generalized connectome-based predictive modeling.

Baijia Xu, Shengxian Ding, Wanwan Xu, Carolyn Fredericks, Yize Zhao

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Baijia XuDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
Shengxian DingDepartment of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT, United States.
Wanwan XuDepartment of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT, United States.
Carolyn FredericksDepartment of Neurology, Yale School of Medicine, Yale University, New Haven, CT, United States.
Yize ZhaoDepartment of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT, United States.

Funding

An integrative Bayesian approach for linking brain to behavioral phenotypeR01EB034720 · NIBIB · YALE UNIVERSITY · PI R Todd Constable, Yize Zhao · 2023 to 2026
$2.4M
Novel integrative imaging genetics analysis for Alzheimer's disease riskand progressionRF1AG068191 · NIA · YALE UNIVERSITY · PI ZHAO, YIZE · 2021 to 2021
$1.9M
Novel integrative imaging genetics analysis for Alzheimer's disease riskand progressionR01AG068191 · NIA · YALE UNIVERSITY · PI ZHAO, YIZE · 2024 to 2025
$1.2M
NIA NIH HHS R01 AG068191NIA NIH HHS RF1 AG068191NIBIB NIH HHS R01 EB034720
6 · The paper itself

Abstract

Understanding brain-behavior relationships and predicting cognitive and clinical outcomes from neuromarkers are central tasks in neuroscience. Connectome-based Predictive Modeling (CPM) has been widely adopted to predict behavioral traits from brain connectivity data; however, existing implementations are largely restricted to continuous outcomes, often overlook essential non-imaging covariates, and are difficult to apply in clinical or disease cohort settings. To address these limitations, we present GenCPM, a generalized CPM framework implemented in open-source R software. GenCPM extends traditional CPM by supporting binary, categorical, and time-to-event outcomes and allows the integration of covariates such as demographic and genetic information, thereby improving predictive accuracy and interpretability. To handle high-dimensional data, GenCPM incorporates marginal screening and regularized regression techniques, including LASSO, ridge, and elastic net, for efficient selection of informative brain connections. We demonstrate the utility of GenCPM through analyses of the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Study and the Alzheimer's Disease Neuroimaging Initiative (ADNI), showing enhanced predictive performance and improved signal attribution compared to standard methods. GenCPM offers a flexible, scalable, and interpretable solution for predictive modeling in brain connectivity research, supporting broader applications in cognitive and clinical neuroscience.

Indexed as

Alzheimer's diseasebrain connectomegeneralized linear modelregularizationsurvival analysis

Identifiers

PMID41089659
PMCPMC12515856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.